NCT07475572 2026-03-16
A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Alvotech Swiss AG
Phase 1 Not yet recruiting
Alvotech Swiss AG
Xijing Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano